The title and the key note of the conference in 2018 is «Russia and the World. Management of the potential growth of the pharmaceutical market». More than one thousand participants and 20 international delegations, including representatives of GMP inspectorates from BRICS, Europe, Japan, Canada, industrial associations, executives and business owners will honor the event.

The agenda is both intensive and interesting. Participants will discuss issues that the pharmaceutical industry is encountering today: future development of the Russian pharmaceutical market, interaction with the international community, government regulatory measures, and many more.

During these three days, world’s leading experts will share their experience and discuss topical issues at plenary sessions, panel discussions, meetings, and workshops.

The initial outcome of Federal Law 140 will be presented at the panel discussion dedicated to the modern regulatory system. Major trends of modern regulatory systems will be demonstrated using case studies from ICH member states. Delegates will also discuss rational use of resources and country-to-country cooperation in the field of GMP, harmonized approach to GMP assessment within PIC/S, recent trends and the status of the PIC/S blueprint on the classification of non-compliances.

The list of topics will include varying approaches to GMP inspections in different regulatory jurisdictions, the impact of global regulatory trends on regulatory compliance and development of medicines, changing focus in GMP regulations in the EEU countries.

The range of topics this year has become much broader. The conference agenda will include the latest industry’s technologies, digital transformation, Pharma-2030 strategy, certification of authorized persons in accordance with EEU requirements, the IV Industrial Revolution, licensing of particular drug groups. Additionally, this year the number of international experts – who will share their experience – significantly increased.

Representatives of businesses that sponsored the conference this year recognized its significance for the industry.

Anton Strekalov, Valenta Pharm CEO, the general partner of the III All-Russia GMP conference, «We believe that the III All-Russian GMP Conference is the most important platform for the exchange of experience between pharmaceutical manufacturers. We are confident that the event will give a boost to production of high quality medicines in our country».

Gedeon Richter has become a strategic partner of the conference this year, «Along with efficacy, safety and accessibility, the primary goal for Gedeon Richter is to ensure the quality of medicines. We are appreciative that three years in a row the GMP Conference allows industry experts to discuss and promptly resolve urgent issues,» said Natalia Volovich, Gedeon Richter’s Deputy CEO, Head of the Registration Department.

Timur Hannanov, CEO of TatKhimPharmPreparaty – also a strategic partner of the conference – has expressed gratitude and support, «This event is a unique platform for views exchange on urgent issues of the Russian pharmaceutical market, as well as on further development of pharmaceutical production strictly following international and Russian GMP standards. Discussions of such caliber are especially important now, as our nation is striving towards modernization and innovative development».

Astellas Pharma and Takeda Pharmaceuticals will be also make partnership contributions to the conference. Whole sessions became possible solely thanks to the support of Akrihin, Amgen, Bosnalijek, PRO.MED.CS Praha a.o., Pharmimex. GEROFARM will act as a special partner of the event.

Thanks to the support received from these companies, participation is free for all representatives of pharmaceutical community.

The Russian Ministry of Industry and Trade and the State Institute of Drugs and Good Practices organized the conference. The Corporate Communications Center “S-Group” will operate the logistical part of the event.

Venue: Korston Business Center, Kazan, ul. Nikolaya Ershova, 1а

You are welcome to submit an application following instructions.